Diabetic Foot Ulcers – Drugs In Development, 2024
Powered by ![]()
Unlock hidden opportunities in the Pharmaceuticals industry
Empower your strategies with our Diabetic Foot Ulcers – Drugs In Development, 2024 report and make more profitable business decisions.
Diabetic foot ulcers are sores that occur on the feet of people with type 1 and type 2 diabetes. Symptoms include sores, ulcers, or blisters on the foot or lower leg; pain; walking with difficulty; black, blue, or red discoloration of the feet; cold feet; and fever, skin redness, or swelling, or other signs of infection. The predisposing factors include diabetic neuropathy, peripheral vascular disease, a foot deformity, and history of tobacco use disorder.
The Diabetic Foot Ulcers drugs in development market research report provide comprehensive information on the therapeutics under development for Diabetic Foot Ulcers, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action and product description of the therapeutics, and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Diabetic Foot Ulcers and features dormant and discontinued products.
Note:
* This is an “on-demand” report and will be delivered within 2 business days (excluding weekends and holidays) of the purchase.
* Certain sections in the report may be removed or altered based on the availability and relevance of data.
| Quick View – Diabetic Foot Ulcers | Key Targets |
|
|
| Key Mechanisms of Action |
|
||
| Key Routes of Administration |
|
||
| Key Molecule Types |
|
||
| Major Companies |
|
||
Scope
- Therapeutics in Development: Covering 73 molecules, with 71 developed by companies and the rest by universities/institutes.
- Analysis Parameters: Offering insights by stage of development, drug target, MoA, RoA, and molecule type for a comprehensive overview.
- Pharmacological Insights: Understand the descriptive pharmacological action of therapeutics.
- Development History: Access the complete research and development history.
- Latest News and Press Releases: Stay updated with the latest developments through comprehensive news coverage.
Reasons to Buy
- Holistic insights: Understand the broad spectrum of Diabetic Foot Ulcers therapeutics, aiding strategic decision-making with insights into stages, targets, MoA, RoA and molecule types.
- Pipeline Exploration: Explore the detailed Diabetic Foot Ulcers pipeline, offering nuanced analysis of drug targets, mechanisms of action and routes of administration for varied decision-making.
- Comprehensive R&D: Access thorough R&D histories, providing a comprehensive understanding of Diabetic Foot Ulcers treatments for adaptable decision-making.
- Save valuable hours: Identify key players steering innovation in therapeutics, enabling strategic partnerships.
Key Players
Adepthera LLCAegleStem Therapeutics
Alan Laboratories Inc
Anterogen Co Ltd
Aposcience AG
APstem Therapeutics Inc
AptaBio Therapeutics Inc
Asia Stem Cell Regenerative Pharmaceutical Co Ltd
Beijing Huafeng Biotechnology Co Ltd
Bio-Bank Corp
Biofilm Pharma
BioTissue Inc
Blue Blood Biotech Corp
Canton Biotechnologies Inc
Cell2Cure Aps
Cellics Therapeutics Inc
Celloryx AG
Cellresearch Corp Pte Ltd
Ceria Therapeutics Inc
Chiesi Farmaceutici SpA
Chrysalis BioTherapeutics Inc
CK Regeon Inc
CSA Biotechnologies LLC
Cynata Therapeutics Ltd
Cytora Ltd
Destiny Pharma Plc
Elphis Cell Therapeutics Co Ltd
Energenesis Biomedical Co Ltd
Health & Biotech Co Ltd
Hoth Therapeutics Inc
Ilya Pharma AB
Lakewood-Amedex Inc
Madam Therapeutics BV
Mallinckrodt Plc
MangoGen Pharma Inc
MediWound Ltd
Mend Therapeutics
MimeTech Srl
Mirae Cell Bio Co Ltd
NovaLead Pharma Pvt Ltd
NOxy Health Products LLC
OliX Pharmaceuticals Inc
Omnio AB
Perpetuum BV
PHAXIAM Therapeutics SA
Promore Pharma AB
Qilu Pharmaceutical Co Ltd
Recce Pharmaceuticals Ltd
RegenETP Inc
RegenInnopharm Inc
Remedor Biomed Ltd
RHEACELL GmbH & Co KG
SaNOtize Research and Development Corp
Scarless Laboratories Inc
Selsym Biotech Inc
SERDA Therapeutics BV
Serodus ASA
Stempeutics Research Pvt Ltd
TechnoPhage SA
TGV-Inhalonix Inc
Therapeutic Systems Research Laboratories Inc
Topadur Pharma AG
Transwell Biotech Co Ltd
Unicyte AG
University of Arizona
Vasomune Therapeutics Inc
Venturis Therapeutics Inc
Zhittya Genesis Medicine Inc
ZZ Biotech LLC
Table of Contents
Table
Figures
Frequently asked questions
Related reports
View more Diabetic Foot Ulcers reports